Masitinib: all 37 studies that test it

Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety of Masitinib in Combination With SoC Versus Placebo in the Treatment of ALS PatientsNot yet recruitingNCT07174492Phase 3
• Masitinib in Patients With Mild Alzheimer's DiseaseNot yet recruitingNCT05564169Phase 3
• Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic TreatmentRecruitingNCT04333108Phase 3
• Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS PatientsRecruitingNCT03127267Phase 3
• Masitinib for the Treatment of Severe Mast Cell Activation SyndromeStatus unknownNCT05449444Phase 2
• Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple SclerosisSuspendedNCT05441488Phase 3
• Masitinib in Patients With Symptomatic Mild to Moderate COVID-19Status unknownNCT05047783Phase 2
• Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19Status unknownNCT04622865Phase 2
• Masitinib in the Treatment of Patients With Severe Uncontrolled Asthma and Elevated Eosinophil LevelsCompletedNCT03771040Phase 3
• Masitinib Plus Gemcitabine in Pancreatic CancerCompletedNCT03766295Phase 3
• Masitinib Plus Docetaxel in Metastatic Castration-resistant Prostate CancerCompletedNCT03761225Phase 3
• Masitinib in Combination With FOLFIRI in Third or Fourth Line of Treatment of Patients With Metastatic Colorectal CancerCompletedNCT03556956Phase 2/3
• Masitinib in Combination With FOLFIRI for Second-line Treatment of Patients With Metastatic Colorectal CancerTerminatedNCT02605044Phase 3
• Masitinib in Combination With Riluzole for the Treatment of Patients Suffering From Amyotrophic Lateral Sclerosis (ALS)CompletedNCT02588677Phase 2/3
• Masitinib in Combination With Gemcitabine in Advanced/Metastatic Epithelial Ovarian Cancer PatientsCompletedNCT02490488Phase 2/3
• Masitinib in Patients With Localized, Primary GIST After Complete Surgery and With High Risk of RecurrenceTerminatedNCT02009423Phase 3
• Masitinib in Patients With Mild to Moderate Alzheimer's DiseaseCompletedNCT01872598Phase 3
• Masitinib in Patients With Gastrointestinal Stromal Tumour After Progression With ImatinibCompletedNCT01694277Phase 3
• Masitinib in Patients With Gastro-Intestinal Stromal Tumour Resistant to ImatinibCompletedNCT01506336Phase 2
• A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Patients With Relapse or Refractory Multiple MyelomaTerminatedNCT01470131Phase 3
• Masitinib in Primary Progressive Multiple Sclerosis or Relapse-free Secondary Progressive Multiple SclerosisCompletedNCT01450488Phase 2
• Masitinib in Treatment of Patients With Severe Persistent Asthma Treated With Oral CorticosteroidsCompletedNCT01449162Phase 3
• Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple SclerosisCompletedNCT01433497Phase 3
• Masitinib in Refractory Active Rheumatoid ArthritisTerminatedNCT01410695Phase 2/3
• Masitinib in Non-Resectable or Metastatic Stage 3/4 Melanoma Carrying a Mutation in the Juxta Membrane Domain of c-KitTerminatedNCT01280565Phase 3
• Masitinib in Patients With Mastocytosis With Handicap and Bearing the D816V MutationCompletedNCT01266369Phase 2
• A Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Activity of Oral AB1010 in Adults Patients With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT01045577Phase 2
• Masitinib in Locally Advanced/Metastatic Gastro-intestinal Stromal Tumour (GIST)CompletedNCT00998751Phase 2
• Activity of Masitinib (AB1010) in Mild to Moderate Alzheimer's DiseaseCompletedNCT00976118Phase 2
• Masitinib in Combination With Methotrexate, in Treatment of Patients With Active Rheumatoid ArthritisCompletedNCT00913432Phase 2
• Masitinib in Relapse or Refractory Multiple Myeloma With t(4/14) Translocation Expressing or Not FGFR3CompletedNCT00866138Phase 2
• Efficacy of Oral AB1010 in Adult Patients With Severe Persistent Corticosteroid Dependent AsthmaCompletedNCT00842270Phase 2
• Efficacy of AB1010 in Patients With Systemic Indolent MastocytosisCompletedNCT00831974Phase 2
• Efficacy of Oral AB1010 in Adult Patients With Active Rheumatoid ArthritisCompletedNCT00831922Phase 2
• Masitinib in Severe Indolent or Smoldering Systemic MastocytosisCompletedNCT00814073Phase 3
• Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST)TerminatedNCT00812240Phase 3
• Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic CancerCompletedNCT00789633Phase 3

← Masitinib overview